Alexion Pharmaceuticals, Inc. (ALXN)
(Delayed Data from NSDQ)
$136.69 USD
+3.56 (2.67%)
Updated May 3, 2019 04:00 PM ET
After-Market: $136.70 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ALXN]
Reports for Purchase
Showing records 1 - 20 ( 277 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Safety Rules: We Upgrade argenx as Survey Points to Market Leadership for Efgartigimod
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
AZN to Withdraw/Refile HSR, Acquisition With ALXN Still Tracks To 3Q21 Closure
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
With Pre-Announcement, Pending AZN Acquisition 4Q20 Update A Quiet One
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
With Most Of The Fireworks Already Shot Off, Looking For Quiet 4Q20 Reporting
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Glomerular Disorders 101: A Deep Dive Primer On Glomerular Dysfunction
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Moving to Neutral; Long Rumored, Now Coming to Fruition With $39B AZN Takeout
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L